Stock Scorer

Regenerative Medical Technology Group Inc. (RMTG)

Regenerative Medical Technology Group Inc. reported revenue of 4M USD for the quarter ending 30 June 2026, up 309.1% from 983.3K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 4M +309.1%
Gross Profit Q2 '26 · ending 30 June 2026 2.6M +340.2%
Operating Income Q2 '26 · ending 30 June 2026 566K —
Net Income Q2 '26 · ending 30 June 2026 -2.9M —
Cost of Revenue Q2 '26 · ending 30 June 2026 1.4M +263.2%
Operating Cash Flow Q2 '26 · ending 30 June 2026 332K —
Free Cash Flow Q2 '26 · ending 30 June 2026 288.5K -12.4%
Shares Outstanding Q2 '26 · ending 30 June 2026 13.2M +5.5%
EPS Q2 '26 · ending 30 June 2026 -0.75 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 5.1M-867.2K-7.8M-1.3M
20242024-12-31 4.1M81.2K-5.6M635.3K
20232023-12-31 2.4M-715.2K-9.8M-804.8K
20222022-12-31 1.5M—-5.5M-1.3M
20212021-12-31 437.9K—-12.9M—
20202020-12-31 55.1K—-5.9M-422.7K
20192019-12-31 30.1K—-2.5M-462.3K
20182018-12-31 50.1K—-2.1M-248.6K
20172017-12-31 29.2K—-377K—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-304M
Q1 '262026-03-312.6M
Q4 '252025-12-311.6M
Q3 '252025-09-301.2M
Q2 '252025-06-30983.3K
Q1 '252025-03-311.4M
Q4 '242024-12-311.5M
Q3 '242024-09-30986.3K
Q2 '242024-06-30793.3K
Q1 '242024-03-31817K
Q4 '232023-12-31615.6K
Q3 '232023-09-30646.8K
Q2 '232023-06-30361.4K
Q1 '232023-03-31786.2K
Q4 '222022-12-31566.3K
Q3 '222022-09-30367.7K
Q2 '222022-06-30297.5K
Q1 '222022-03-31298.7K
Q4 '212021-12-31252.6K
Q3 '212021-09-30165K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-302.6M
Q1 '262026-03-311.8M
Q4 '252025-12-31779.5K
Q3 '252025-09-30501.6K
Q2 '252025-06-30585.6K
Q1 '252025-03-31943.9K
Q4 '242024-12-31980.2K
Q3 '242024-09-30747.1K
Q2 '242024-06-30526.9K
Q1 '242024-03-31569K
Q4 '232023-12-31434.7K
Q3 '232023-09-30450.3K
Q2 '232023-06-30253.8K
Q1 '232023-03-31536.8K
Q4 '222022-12-31358.8K
Q3 '222022-09-30264.9K
Q2 '222022-06-30147K
Q1 '222022-03-31106.3K
Q4 '212021-12-3180.1K
Q3 '212021-09-3076.5K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30566K
Q1 '262026-03-31229.8K
Q4 '252025-12-31-306.3K
Q3 '252025-09-30-445.8K
Q2 '252025-06-30-250.1K
Q1 '252025-03-31135K
Q4 '242024-12-31380.6K
Q3 '242024-09-3019.6K
Q2 '242024-06-30-214K
Q1 '242024-03-31-105.1K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-2.9M
Q1 '262026-03-31-876.3K
Q4 '252025-12-31-1.4M
Q3 '252025-09-30-4.4M
Q2 '252025-06-30-1.4M
Q1 '252025-03-31-760K
Q4 '242024-12-31-638.2K
Q3 '242024-09-30-887.1K
Q2 '242024-06-30-2.1M
Q1 '242024-03-31-2M
Q4 '232023-12-31-256K
Q3 '232023-09-30-5.9M
Q2 '232023-06-30-2M
Q1 '232023-03-31-1.7M
Q4 '222022-12-31-992.4K
Q3 '222022-09-30-1.3M
Q2 '222022-06-30-1.5M
Q1 '222022-03-31-1.7M
Q4 '212021-12-31-1.6M
Q3 '212021-09-30-9.9M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-301.4M
Q1 '262026-03-31872.9K
Q4 '252025-12-31792.4K
Q3 '252025-09-30679K
Q2 '252025-06-30397.7K
Q1 '252025-03-31420.4K
Q4 '242024-12-31530.6K
Q3 '242024-09-30239.2K
Q2 '242024-06-30266.4K
Q1 '242024-03-31248K
Q4 '232023-12-31180.8K
Q3 '232023-09-30196.5K
Q2 '232023-06-30107.5K
Q1 '232023-03-31249.4K
Q4 '222022-12-31207.4K
Q3 '222022-09-30102.8K
Q2 '222022-06-30150.6K
Q1 '222022-03-31192.5K
Q4 '212021-12-31172.6K
Q3 '212021-09-3088.5K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30332K
Q1 '262026-03-31102.1K
Q4 '252025-12-3138.2K
Q3 '252025-09-30-203.7K
Q2 '252025-06-30-598.1K
Q1 '252025-03-3157.1K
Q4 '242024-12-31379.4K
Q3 '242024-09-30272.9K
Q2 '242024-06-3090.4K
Q1 '242024-03-31108K
Q4 '232023-12-31-29.4K
Q3 '232023-09-3010.1K
Q2 '232023-06-30-406.7K
Q1 '232023-03-316.8K
Q4 '222022-12-31-49.4K
Q3 '222022-09-30-152.2K
Q2 '222022-06-30-396.4K
Q1 '222022-03-31-516.1K
Q4 '212021-12-31-8.7M
Q3 '212021-09-30-430.7K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30288.5K
Q1 '262026-03-31-213.3K
Q4 '252025-12-31-229K
Q3 '252025-09-30-428.6K
Q4 '242024-12-31329.4K
Q3 '242024-09-30219.3K
Q2 '242024-06-3037.7K
Q1 '242024-03-3148.8K
Q4 '232023-12-31-313.4K
Q3 '232023-09-30-81.2K
Q2 '232023-06-30-411.4K
Q1 '232023-03-311.3K
Q4 '222022-12-31-118K
Q3 '222022-09-30-153.4K
Q1 '212021-03-31-254.9K
Q4 '202020-12-31-96.9K
Q3 '202020-09-30-92.1K
Q2 '202020-06-30-69K
Q1 '202020-03-31-164.7K
Q4 '192019-12-31-48.5K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3013.2M
Q1 '262026-03-3113.1M
Q3 '252025-09-3012.5M
Q2 '252025-06-3012.5M
Q1 '252025-03-3112.5M
Q3 '242024-09-3012.5M
Q2 '242024-06-3012.5M
Q1 '242024-03-3112.5M
Q3 '232023-09-3012.4M
Q2 '232023-06-3012.4M
Q1 '232023-03-3112.4M
Q3 '222022-09-3012M
Q2 '222022-06-3012.2M
Q1 '222022-03-3112.1M
Q3 '212021-09-3012M
Q2 '212021-06-3010.9M
Q1 '212021-03-3110.9M
Q3 '202020-09-309.9M
Q2 '202020-06-308.7M
Q1 '202020-03-318.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.75
Q1 '262026-03-31-0.65
Q4 '252025-12-31-0.64
Q3 '252025-09-30-0.58
Q2 '252025-06-30-0.30
Q1 '252025-03-31-0.35
Q4 '242024-12-31-0.45
Q3 '242024-09-30-0.42
Q2 '242024-06-30-0.82
Q1 '242024-03-31-0.81
Q4 '232023-12-31-0.78
Q3 '232023-09-30-0.84
Q2 '232023-06-30-0.48
Q1 '232023-03-31-0.44
Q4 '222022-12-31-0.45
Q3 '222022-09-30-0.49
Q2 '222022-06-30-1.20
Q1 '222022-03-31-1.16
Q4 '212021-12-31-1.06
Q3 '212021-09-30-0.33